1,027 results on '"Chen, Zhe-Sheng"'
Search Results
2. Nanotechnology-based delivery systems to overcome drug resistance in cancer
3. Synthesis and clinical application of new drugs approved by FDA in 2022
4. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
5. Epigenetic modification of m6A regulator proteins in cancer
6. Gold nanoparticles and gold nanorods in the landscape of cancer therapy
7. Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair
8. Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
9. Advancements in nanoparticle-based treatment approaches for skin cancer therapy
10. New opportunities for RGD-engineered metal nanoparticles in cancer
11. Electroacupuncture facilitates vascular normalization by inhibiting Glyoxalase1 in endothelial cells to attenuate glycolysis and angiogenesis in triple-negative breast cancer
12. Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
13. New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma
14. Targeting anoikis resistance as a strategy for cancer therapy
15. VISTA: A Novel Checkpoint for Cancer Immunotherapy
16. Dostarlimab in the treatment of mismatch repair deficient recurrent or advanced endometrial cancer
17. A novel nitric oxide-driven nanomotor for synergistic treatment of ischaemic stroke: Enhanced deep brain penetration and therapeutic efficacy
18. Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration
19. Stepwise targeted strategies for improving neurological function by inhibiting oxidative stress levels and inflammation following ischemic stroke
20. Targeting autophagy to counteract neuroinflammation: A novel antidepressant strategy
21. Ferroptosis as a potential therapeutic target for age-related macular degeneration
22. ABCB1-dependent collateral sensitivity of multidrug-resistant colorectal cancer cells to the survivin inhibitor MX106-4C
23. Targeting ZIP8 mediated ferroptosis as a novel strategy to protect against the retinal pigment epithelial degeneration
24. Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor
25. AR/RKIP pathway mediates the inhibitory effects of icariin on renal fibrosis and endothelial-to-mesenchymal transition in type 2 diabetic nephropathy
26. Ligands and receptors in human cytomegalovirus entry: Current therapies and new directions
27. Recent review of COVID-19 management: diagnosis, treatment and vaccination
28. Bridging cultures: Chinese elements in scientific illustrations
29. Understanding the Novel Approach of Nanoferroptosis for Cancer Therapy
30. SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest
31. Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells
32. lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2
33. A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency
34. Recent advances in biomimetic nanodelivery systems: New brain-targeting strategies
35. Design, synthesis, and biological evaluation of phenylurea indole derivatives as ABCG2 inhibitors
36. Susceptibility of Lung Carcinoma Cells to Nanostructured Lipid Carrier of ARV-825, a BRD4 Degrading Proteolysis Targeting Chimera
37. Antimicrobial peptides for combating drug-resistant bacterial infections
38. Silver-dendrimer nanocomposite as emerging therapeutics in anti-bacteria and beyond
39. Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers
40. Small Molecule Inhibitors That Target Signal Transduction Pathways Involved in Oxidative Stress-Induced Cancer : Current Status and Future Directions
41. Recent Advances in the Development of Synthetic Pro-oxidants: Implications for ROS-Based Cancer Therapeutics : Implications for ROS-Based Cancer Therapeutics
42. Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
43. CCT251545 enhances drug delivery and potentiates chemotherapy in multidrug-resistant cancers by Rac1-mediated macropinocytosis
44. ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance
45. Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer
46. PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN
47. PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study
48. m6A modification: recent advances, anticancer targeted drug discovery and beyond
49. Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma
50. Signaling pathways and therapeutic interventions in gastric cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.